Clinical Trial

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

Name: Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma — clinical trial record (NCT07333430)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase 1a/1b Open-Label Study with Dose Escalation and Expansion Phases to Evaluate Safety and Preliminary Efficacy of Naïve HBI0101 CART Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma.

Trial Details

NCT Number	NCT07333430
Lead Sponsor	Hadassah Medical Organization
Conditions	Relapsed/Refractory Multiple Myeloma (MM)
Enrollment	60 participants
Start Date	2026-01-15
Primary Completion	2027-12-01 (estimated)
Study Completion	2030-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-12